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Abstract Sodium-independent anion exchangers (AE1^4) show
remarkable variability in their tissue-speci¢c expression and
subcellular localization. Currently, isoform-speci¢c targeting
mechanisms are considered to be responsible for this variable
localization. Here, we report that targeting can also be cell
type-speci¢c. We show that the full-length AE2 protein and
its green £uorescent protein- or DsRed-tagged variants localize
predominantly either to the Golgi apparatus in COS-7 cells, or
to the plasma membrane in HeLa cells. This alternative target-
ing did not seem to result from either translational or post-
translational di¡erences, but rather from di¡erential expression
of at least one of the Golgi membrane skeletal proteins,
ankyrin195 (Ank195), between the two cell types. Comparative
studies with several di¡erent cell lines revealed that the Golgi
localization of the AE2 protein correlated strictly with the ex-
pression of Ank195 in the cells. The two Golgi-associated pro-
teins also co-localized well and similarly resisted detergent ex-
traction in the cold, whereas the plasma membrane-localized
AE2 in Ank195-de¢cient cells was mostly detergent-soluble. Col-
lectively, our results suggest that Ank195 expression is a key
determinant for the variable and cell type-dependent localization
of the AE2 protein in the Golgi apparatus in mammalian cells.
4 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Naþ-independent anion exchangers (AE) are ubiquitously
expressed transmembrane proteins that regulate intracellular
pH, cell volume, and chloride concentration in cells by medi-
ating an electroneutral exchange of chloride for bicarbonate.
Currently, four distinct members (AE1^4) in this gene family
have been identi¢ed and characterized [1^7]. Structurally, all
AE proteins are type III membrane proteins with a large
cytosolic N-terminal domain, and a C-terminal anion trans-
port domain that consists of 12^14 membrane-spanning do-
mains. The extreme C-terminus (V40 amino acids) is also
cytosolic.
In most tissues, each gene gives rise into multiple N-termi-
nally truncated variants either by means of tissue-speci¢c
mRNA splicing or by the use of alternative promoters [8,9].
The physiological role of these N-terminal truncations has
remained obscure, but they may either have a regulatory
role or they may possess speci¢c targeting information needed
for delivery of each of these variants to their correct destina-
tions [8^10]. There is substantial evidence to support the latter
possibility. For example, the N-terminally truncated mamma-
lian AE1 and AE2 variants have been localized to the baso-
lateral plasma membrane of kidney tubule epithelial cells [11],
whereas the full-length AE2 (AE2a) isoform has been shown
to localize to the apical plasma membrane in biliary and in-
testinal epithelial cells and in hepatocytes [12^14]. Second, of
the four chicken erythrocyte N-terminal AE1 variants charac-
terized thus far [10], only one with an additional exon is
targeted to intracellular membrane systems, whereas the
others are localized to the plasma membrane. Third, in
many instances AE proteins are known to co-localize and to
interact with the well-known cytoskeletal adapter proteins
termed ankyrins [15^18]. This interaction is thought to be
crucial for anchoring the AE1 and AE2 isoforms to the baso-
lateral membrane of kidney L-intercalated cells and in gastric
parietal cells. However, contradictory results for the AE2 pro-
tein have been reported in choroid plexus epithelial cells [19].
Fourth, the ankyrin binding sites in these proteins have been
mapped within their variable N-terminal domains [20^23].
Because of this, the major ankyrin binding site in the N-ter-
minally truncated kidney AE1 isoform is lost [24]. The kidney
AE1, however, has been shown to bind to kanadaptin, a novel
cytoplasmic protein expressed mainly in the kidney, liver,
lungs, brain, and skeletal and cardiac muscle [25]. This inter-
action seems to be involved in localization of the AE1 in the
apical, but not the basolateral, plasma membrane in kidney
epithelial cells [25].
We [26] and others [10,11] have previously shown that some
AE isoforms are also found in the membranes of the Golgi
apparatus. Recently, we identi¢ed this Golgi-associated AE
protein as the full-length AE2 (AE2a) isoform [27]. This ¢nd-
ing was somewhat surprising, as it opposes the characteristic
plasma membrane localization of this AE isoform in epithelial
cells [11^14], including mammalian sperm cells, according to
our own results [28,29]. However, there are two possibilities
that could explain this apparent discrepancy in targeting of
the same isoform in two di¡erent subcellular locations. One of
these is that targeting is plastic and under control of external
cues, as previously suggested [30]. The other possibility is that
targeting is cell type-dependent. Given the co-localization and
suggested cytoskeletal interactions in targeting of the plasma
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membrane-associated AE isoforms, and the known existence
of two ankyrin isoforms [31,32] and one spectrin isoform
[33,34] in the Golgi membranes, either possibility could in-
volve reversible and/or regulated interactions with these Golgi
membrane skeletal proteins.
In this report, we have addressed these issues by comparing
the synthesis, processing, detergent resistance and targeting of
the full-length AE2 protein and its green £uorescent protein
(GFP)/DsRed-tagged variants in di¡erent cell types. Our re-
sults show that the AE2 isoform is indeed targeted in a cell
type-dependent manner either to the Golgi apparatus or to
the plasma membrane. The results also suggest that this di¡er-
ential targeting between the cell types depends on their di¡er-
ential expression of the trans-Golgi-associated ankyrin195
(Ank195) isoform.
2. Materials and methods
2.1. Antibodies and reagents
The antibody against the AE2 C-terminal peptide (amino acids
1229^1241) was prepared as previously described [28]. The pDs-
Red-C1 vector, pE-GFP-C1 vector and the GFP antibodies were
from Clontech. Alexa Fluor-conjugated secondary antibodies were
from Molecular Probes (Eugene, OR, USA). The peroxidase-conju-
gated secondary antibodies were from P.A.R.I.S. (Compie'gne,
France). The antibodies against Golgi ankyrins, AnkG119 and
Ank195, were kind gifts from Drs. Jon Morrow (Yale University
School of Medicine, New Haven, CT, USA) and Kenneth Beck (Uni-
versity of California, Davis, CA, USA).
2.2. Cell cultures and indirect immuno£uorescence
COS-7 cells were grown in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) with Glutamax (Gibco, Grand Island, NY, USA) supple-
mented with 10% fetal calf serum and penicillin^streptomycin. HeLa
cells were cultured in MEM with Glutamax supplemented with 10%
fetal calf serum, penicillin^streptomycin and non-essential amino
acids. CHO-K1, NRK, MDCK and MDBK cells were cultured in
media recommended by ATCC.
Cells were processed for indirect immuno£uorescence as described
elsewhere [26]. Brie£y, cells cultured on glass coverslips were washed
two or three times with phosphate-bu¡ered saline (PBS), and then
¢xed with 3.7% formaldehyde in PBS for 20^30 min. After washing
with PBS, cells were immunostained with the antibodies in the pres-
ence of 0.1% saponin. Stained specimens were examined using an
epi£uorescence microscope and a CCD camera (Olympus BX-60
microscope).
2.3. GFP- and DsRed-AE2 fusion protein constructs and cell
transfections
The GFP-AE2 fusion protein was prepared as described previously
[28]. By using the same HindIII and EcoRI restriction enzymes, the
full-length AE2a cDNA was also subcloned into the pDs-Red-C1
vector. Transfections with the plasmid constructs, pDs-Red-AE2
and pE-GFP-AE2 constructs (2 Wg/plate), were done using the Fu-
gene-6 transfection reagent (Roche Diagnostics) on cells plated 1 day
earlier. Transfected cells were examined 24^48 h after the transfec-
tions.
2.4. Construction of glycosylation and phosphorylation site mutants
N-Glycosylation and tyrosine kinase phosphorylation site muta-
tions were made with the QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA, USA). The AE2 protein sequence contains
three potential N-glycosylation sites (consensus: Asn-X-Ser/Thr) in
positions N859, N868 and N882. These asparagines were mutated
to glutamines. The primer pairs designed for this purpose were:
F859, 5P-CTGCTCAGCCTCCCAAAGCTCAGAGGTGG-3P (nt
2562^2590) and R859, 5P-CCACCTCTGAGCTTTGGGAGGCT-
GAGCAG-3P ; F868, 5P-ACGGCGGTGAGCAAATGACATGGG-
CC-3P (nt 2591^2616) and R868, 5P-GGCCCATGTCATTTGCT-
CACCGCCGT-3P ; F882, 5P-ACGCTGGGGCCGGGCCAAAGGA-
GCTTGG-3P (nt 2629^2656) and R882, 5P-CCAAGCTCCT-
TTGGCCCGGCCCCAGCGT-3P (F forward primer; R reverse prim-
er; corresponding codons are underlined).
Two potential tyrosine kinase phosphorylation sites were identi¢ed
in the AE2 sequence (residues 590 and 1154) using the ExPASy pro-
tein analysis program (Swiss Institute of Bioinformatics). The primer
pairs used for mutating each of these tyrosines to asparagine (Y590N,
F1136N, and Y1154N) were F590/R590 (5P-ACGAGGCAGCC-
AACCTGGCTGACG-3P/5P- CGTCAGCCAGGTTGGCTGCCTC-
GT-3P) and F1154/R1154 (5P-AGATGTCACTAACGTCAAGAAG-
G-3P/5P-CCTTCTTGACGTTAGTGACATCT-3P). We also mutated
the tyrosine residue 1136 present in the ^YERL^ sequence (see
Section 3), using the primer pair F1136/R1136 (5P-GGGATCC-
AGTTCAACGAGCGGCTGCAT -3P/5P-ATGCAGCCGCTCGTTG-
AACTGGATCCC-3P). All mutations were made according to the
manufacturer’s instructions.
2.5. Detergent extraction with Triton X-100
COS-7 and HeLa cells were cultured on coverslips to about 50^70%
con£uence. The cells were washed three times with PBS at 20‡C and
cooled on ice for 5 min. Ice-cold 1% Triton X-100 in TKM bu¡er (20
mM Tris, 10 mM KCl, 1 mM MgCl2, pH 6.2) supplemented with
protease inhibitors (Mini protease inhibitor tablets, Roche Diagnos-
tics) was then added, and incubated for 30 min in an orbital shaker on
ice. After detergent extraction, cells were rinsed brie£y with PBS and
¢xed and stained prior to £uorescence microscopy. In control experi-
ments, cells were ¢xed before the detergent extraction protocol.
2.6. Immunoblotting
Immunoblotting of endogenous AE2 protein was performed using
native polyacrylamide gel electrophoresis (PAGE) gels, because the
epitope recognized by the AE2 antibody has been shown to be sodium
dodecyl sulfate (SDS)-sensitive [11]. Brie£y, cells were washed two or
three times with PBS and lysed directly on ice into 50 mM Tris, 150
mM NaCl, 1% Nonidet P-40, pH 8.0 [35] supplemented with protease
inhibitors (Mini protease inhibitor tablets). After removal of insoluble
material by centrifugation, 2UPAGE sample bu¡er was added, and
the samples were then heated for 3 min at 94‡C before subjection to
PAGE using 4^12% Tris-glycine gradient gels (Novex). Samples were
transferred onto a nitrocellulose ¢lter and probed with the anti-AE2
antibody followed by peroxidase-conjugated secondary anti-rabbit
antibodies (P.A.R.I.S.). The bands were visualized using the ECL
detection system and Hyper¢lm ECL (Amersham).
Immunoblotting with the anti-Ank195 and anti-GFP antibodies was
performed as follows: cells (untransfected and transfected) were
washed two or three times with PBS and lysed directly with SDS^
PAGE sample bu¡er supplemented with protease inhibitors and a
reducing agent (5% mercaptoethanol). Alternatively, washed cells
(on plates) were ¢rst subjected to detergent extraction (as described
above, except that Triton X-100 was used instead of Nonidet P-40),
prior to solubilization of the remaining insoluble material with the
SDS sample bu¡er. After treatments, equal amounts of the Triton
X-100- and SDS-solubilized samples were subjected to SDS^PAGE
and immunoblotting with the anti-Ank195- and anti-GFP antibodies.
When applicable, DNA was sheared from the samples by vortexing
(1500 rpm, 2 h).
2.7. Cell surface biotinylation
Biotinylation of GFP-AE2 transfected cells was performed as de-
scribed by Li et al. [36]. Brie£y, cells were treated on ice for 1 h with
0.5 mg/ml sulfo-NHS-LC-biotin (Pierce, Rockford, IL, USA) in bo-
rate bu¡er (10 mM boric acid, 154 mM NaCl, 7.2 mM KCl, 1.8 mM
CaCl2). After rinsing, cells were solubilized with a bu¡er containing
1% deoxycholate, 1% Triton X-100, 10 mM Tris, 150 mM NaCl and
1 mM EDTA (pH 7.5). After centrifugation, biotinylated proteins
were absorbed from the supernatant using immobilized streptavidin
beads (Sigma). Total, bound and unbound fractions were collected
and subjected to SDS^PAGE before immunoblotting with the mono-
clonal anti-GFP antibody. The intensity of the bands was quantitated
using the Scion image analysis program.
3. Results
3.1. Localization of the AE2 protein is cell type-dependent
Using the anti-AE2 C-terminal peptide antibody, we have
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previously shown that the full-length AE2 protein is expressed
in the Golgi membranes mainly in ¢broblast-like cell types
both in vivo and under normal cell culture conditions
[26,27]. To assess ¢rst whether the endogenous AE2 protein
is localized di¡erently in epithelial cells, as suggested by the in
vivo data [11^14], we screened a number of established cell
lines with the same anti-AE2 antibody. During our initial
screens, we found (Fig. 1) that in HeLa cells the staining
pattern was clearly reminiscent of the plasma membrane stain-
ing, and not the characteristic Golgi staining pattern seen in
COS-7 cells (Fig. 1). Both the lateral cell borders and the
whole cell surface were stained, and intracellular or Golgi
staining was undetectable. To allow comparisons, we stained
COS-7 and HeLa cells with the Golgi marker antibody,
GM130, and found (Fig. 1) that both cell types possessed a
similar, compact juxtanuclear Golgi apparatus.
To con¢rm that the same full-length AE2 isoform is tar-
geted di¡erently between COS-7 and HeLa cells, we transi-
ently expressed both the GFP- or DsRed-tagged AE2 fusion
proteins and followed their distribution in these cells. As
shown in Fig. 2, the GFP-tagged AE2 fusion protein local-
ized, similarly to the endogenous AE protein, predominantly
to the Golgi apparatus in COS-7 cells. In HeLa cells, the
GFP-AE2 fusion protein did not accumulate in the Golgi
region, but instead was detected mainly at the plasma mem-
brane (Fig. 2). Transiently expressed DsRed-AE2 fusion pro-
tein gave identical results, i.e. it accumulated in the Golgi
region in COS-7 cells and in the plasma membrane in HeLa
cells (data not shown). Based on cell surface biotinylation, we
estimated that 18.5% of the GFP-AE2 fusion protein was ex-
pressed at the cell surface in COS-7 cells, and 65.5% in HeLa
cells. These values are fully consistent with our microscopical
observations, which show that in addition to the Golgi region,
a proportion of the GFP-AE2 fusion protein is detected in the
plasma membrane in COS-7 cells, and in intracellular/Golgi
membranes in HeLa cells. These results show that the full-
length AE2 isoform is indeed targeted in a cell type-dependent
manner mainly to the Golgi apparatus in ¢broblast-like COS-
7 cells and to the plasma membrane in epithelial HeLa cells.
3.2. Post-translational processing of the AE2 protein
To assess whether translational or post-translational pro-
cessing di¡erences between COS-7 and HeLa cells are respon-
sible for their alternative targeting of the AE2, we ¢rst com-
pared the molecular size of the endogenous AE2 protein
expressed in these cells. Because the AE2 C-terminal epitope
is sensitive to SDS [11], native gel electrophoresis system was
used for this purpose. Immunoblotting with the anti-AE2
C-terminal antibody (Fig. 3A) showed that only one protein
band was detected near the top of the native 4^12% PAGE gel
in both COS-7 and HeLa cells. The bands had identical mi-
gration rates in this gel system, indicating that the AE2 pro-
teins expressed by these cells do not markedly di¡er from each
other.
Similar results were obtained when the GFP-tagged AE2
fusion protein was expressed in these cells. With the anti-
GFP monoclonal antibody, we detected two di¡erent-sized
bands in both cell types (Fig. 3B). The major, lower molecular
Fig. 1. Localization of the endogenous AE2 protein in COS-7 and
HeLa cells. Cells grown on glass coverslips were stained either with
the AE2 C-terminal peptide antibody (AE2), or with the anti-
GM130 antibody (GM130, a Golgi marker). Note that the AE2
protein is localized mainly in the Golgi apparatus in COS-7 cells,
whereas in HeLa cells the protein accumulates in the plasma mem-
brane. Bar, 10 Wm.
Fig. 2. Localization of the GFP-tagged full-length AE2 protein in
COS-7 and HeLa cells. Cells were grown on glass coverslips, and
transfected transiently with the plasmid encoding the full-length
AE2 protein tagged N-terminally with the GFP protein. After 24 h,
cells were ¢xed and examined by £uorescence microscopy. The
DsRed-tagged full-length AE2 protein gave identical results (data
not shown). Bars, 10 Wm.
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weight band (about 190 kDa) probably represents unglycosy-
lated AE2 protein, since this band was detected also in the
presence of tunicamycin, a drug that inhibits N-linked glyco-
sylation (data not shown, see also below). The higher molec-
ular weight band (about 230 kDa) probably represents glyco-
sylated GFP-AE2 fusion protein. These values correspond
well to the calculated molecular size of the GFP-AE2 poly-
peptide chain (GFP, 27 kDa; AE2, 165 kDa). In addition to
these monomeric protein bands, we often detected two other
minor bands with much higher molecular weight in both cell
types. These probably represent homodimeric and homotetra-
meric forms of the GFP-AE2 fusion protein (data not shown,
see below).
To evaluate the glycosylation state of the expressed GFP-
AE2 fusion protein in the two cell types, we sequentially mu-
tated all three potential N-glycosylation sites (asparagine in
positions 859, 868 and 882) in the AE2 sequence to glutamine,
which has the same hydrophobicity and charge (Fig. 3B).
Mutation of the ¢rst (N859Q) asparagine was not found to
a¡ect the molecular size or the localization of the fusion pro-
tein in either cell line (data not shown). However, an addi-
tional mutation of the next asparagine (N868Q; dsmut) re-
duced the molecular size of both the monomeric and
oligomeric forms of the fusion protein similarly in both cell
types. This mutant protein also accumulated in the endoplas-
mic reticulum in both cell types (data not shown). Finally,
when the last asparagine was also mutated (N882Q, tsmut),
in both cell types the triple mutant protein accumulated in the
endoplasmic reticulum and migrated as a sharp band with a
molecular weight of about 195 kDa (Fig. 3B), i.e. the calcu-
lated size of the complete GFP-AE2 polypeptide chain and
the size of the band detected also in the presence of tunica-
mycin. This band therefore represents the unglycosylated form
of the GFP-AE2 fusion protein. Collectively, these results in-
dicate that the last two potential N-glycosylation sites in the
AE2 sequence are used in both COS-7 and HeLa cells, and
that major glycosylation di¡erences do not exist between these
two cell types. The results also suggest that although N-linked
glycosylation appears not to be important for either the Golgi
or the plasma membrane localization of the AE2 protein in
these cells, it seems to be necessary for correct folding of the
AE2 protein and for its transport out of the endoplasmic
reticulum.
The ¢rst one of the potential tyrosine kinase phosphoryla-
tion sites found in the AE2 protein sequence is located within
the KQFHEAAY sequence (amino acids 573^580), near the
Fig. 3. Immunoblotting of the AE2 protein expressed in COS-7 and
HeLa cells. A, Left: The endogenous AE2 protein was detected
from total cell lysates with the C-terminal AE2 peptide antibody us-
ing native polyacrylamide gels (4^12% Novex). Note that in both
cell types, only one major band of the same molecular size was de-
tected with the antibody. Right: Immunoblotting of the expressed
GFP-AE2 fusion protein in COS-7 and HeLa cells. The fusion pro-
tein was detected using the monoclonal anti-GFP antibody, which
recognized identical fusion protein bands in both cell types. The
faster migrating band represents the unglycosylated form of the fu-
sion protein (195 kDa), whereas the upper band represents the fully
glycosylated form of the fusion protein. B: Immunoblotting of the
di¡erent N-glycosylation mutants of the GFP-AE2 fusion protein in
COS-7 and HeLa cells. Note that in both cell lines, the molecular
sizes of the mutated proteins (dsmut=N859+868Q; tsmut=
N859+868+882Q) are lower than that of the wild type protein.
Note also that each mutant has an identical size when expressed in
either COS-7 or HeLa cells. The tsmut protein (which lacks all the
potential glycosylation sites) represents the non-glycosylated form of
the fusion protein. The high molecular weight bands (arrows) prob-
ably represent dimeric and tetrameric forms of the fusion protein.
Fig. 4. Detergent solubility of the GFP-AE2 fusion protein in
COS-7 and HeLa cells. Cells transiently transfected with the GFP-
AE2 fusion protein-encoding plasmid were extracted with ice-cold
Triton X-100, ¢xed and examined directly with a £uorescence
microscope. Notice that the Golgi-localized AE2 protein in COS-7
cells resists detergent extraction in the cold, whereas no plasma
membrane-associated GFP £uorescence can be detected in HeLa
cells after detergent extraction. Only some residual £uorescence is
present intracellularly in Triton X-100-treated HeLa cells. Bar, 10
Wm.
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¢rst transmembrane domain. The other one is located within
the last intracellular loop (KHHPDVTY sequence, amino
acids 1147^1154). To exclude these two sites as potential ef-
fectors for targeting di¡erences, we mutated these tyrosines to
asparagines in both sequence motifs (Y580N, Y1154N). The
mutations, however, did not a¡ect the localization of the
GFP-AE2 fusion protein in either cell type (data not shown).
The AE2 C-terminal cytoplasmic tail also has a ^YERL^ se-
quence (residues 1136^1139) which is reminiscent of the well-
known C-terminal tyrosine-based internalization motif
(YQRL^) of the TGN38 protein [37]. Mutation of this tyro-
sine residue also did not change the distribution of the fusion
protein in either COS-7 or HeLa cells (data not shown).
3.3. Detergent solubility of the expressed GFP-AE2 fusion
protein
Proteins that either associate with cytoskeletal proteins, are
present in lipid rafts [38,39] or form large oligomeric com-
plexes [40], are characteristically resistant to Triton X-100
extraction in the cold. Therefore, we compared the detergent
solubility of the Golgi- and the plasma membrane-localized
GFP-AE2 fusion protein expressed in COS-7 and HeLa cells.
We found, similarly to our earlier data [27], that a substantial
proportion of the Golgi-localized AE2 fusion protein could
not be solubilized with the Triton X-100 in intact cells (Fig.
4). In contrast, the plasma membrane-localized AE2 fusion
protein appeared to be completely soluble, as evidenced by
our inability to detect any cell surface-associated £uorescence
in detergent-treated HeLa and COS-7 cells. Only some resid-
ual intracellular £uorescence was detected in HeLa cells after
detergent extraction (Fig. 4). Pre¢xation of the cells prevented
the solubilization of this plasma membrane-associated GFP-
AE2 fusion protein (data not shown). Similar results were
obtained with the DsRed-AE2 fusion protein in both cell
types (data not shown).
3.4. Association of the AE2 fusion protein with the Golgi
membrane skeleton
Based on its detergent resistance (Fig. 4), and the ability of
some AE proteins to associate with ankyrins, we next consid-
ered the possibility that the Golgi-localized GFP-AE2 protein
may be associated with either of the two ankyrin isoforms,
AnkG119 or Ank195 [32^34] identi¢ed in the Golgi thus far.
Of these two, the Ank195 isoform is the more probable candi-
Fig. 5. Expression of Golgi-associated Ank195 in COS-7 and HeLa
cells. Cells grown on glass coverslips were detergent-extracted, ¢xed
and stained with the anti-Ank195 antibody. Indirect immuno£uores-
cence shows staining of Golgi-associated Ank195 in COS-7 cells (ar-
rowhead). In HeLa cells, the same antibody does not recognize a
similar Golgi-like staining pattern. In both cell types, detergent
extraction also resulted in staining of the nuclei (asterisks). Bar,
10 Wm.
Fig. 6. Immunoblotting of Ank195 in COS-7 and HeLa cells. Left:
Cells were solubilized directly in SDS sample bu¡er. Cleared total
cell lysates were then subjected to SDS^PAGE before transfer onto
a nitrocellulose ¢lter. Immunoblot with the anti-Ank195 antibody
shows a band with the apparent molecular size (193 kDa; arrow-
head) of Ank195 protein in COS-7 cells, but not in HeLa cells.
Right: Immunoblotting of COS-7 cells solubilized ¢rst with Triton
X-100 (TX) and then with SDS. The blot shows that the 193 kDa
band (arrowhead) is Triton X-100-insoluble.
Fig. 7. Expression of the Ank195 in di¡erent cell lines. Cells grown
on plates were sequentially extracted with Triton X-100 (TX) and
SDS, as described in Section 2. Samples were then subjected to
SDS^PAGE, and immunoblotted with the anti-Ank195 antibody.
The blot shows the presence of the Triton X-100-insoluble 193 kDa
band (arrow) in NRK, CHO-K1 and MDBK cells. Note also that
MDCK cells do not express this Triton X-100-insoluble ankyrin iso-
form.
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date, as it is also resistant to Triton X-100 extraction [32] and
like AE2 [26] it is concentrated in the trans-Golgi area [32].
Our initial cell stainings with the Ank195 antiserum revealed
that it cross-reacts with several other ankyrin isoforms, as
previously reported [32]. We, therefore, used detergent extrac-
tion to remove detergent-soluble ankyrin isoforms before
staining of the cells. We found that in detergent-extracted
COS-7 cells, the antiserum stained juxtanuclear Golgi-like
structures, in addition to the nuclei (Fig. 5). However, in
HeLa cells, despite the staining of the nuclei, no staining
was observed in the juxtanuclear Golgi region, suggesting
that HeLa cells do not express this ankyrin isoform. Our
subsequent immunoblotting experiments with the same serum
(Fig. 6) revealed a strong band of 193 kDa in COS-7 cells, but
not in HeLa cells, thus con¢rming that COS-7 cells express
the Ank195 isoform. Sequential fractionation of the cells with
Triton X-100 and SDS revealed that this protein band in
COS-7 cells is also Triton X-100-insoluble (Fig. 6).
Thus far, our attempts to directly demonstrate that the two
proteins interact with each other have failed, mainly because
the anti-Ank195 antiserum or the a⁄nity-puri¢ed anti-AE2
antibodies do not work well for immunoprecipitation. To
provide additional evidence for their potential interaction,
we screened several other cell lines by immunoblotting and
indirect immuno£uorescence with the Ank195 antiserum and
the anti-AE2 antibodies, respectively. As shown in Fig. 7, the
Ank195 antiserum recognized a Triton X-100-insoluble 193
kDa band in most cell types including NRK, CHO-K1 and
MDBK cells, but not in MDCK cells. Indirect immuno£uo-
rescence showed that the same cells also expressed the AE2
protein in the Golgi membranes (Fig. 8), whereas in Ank195-
de¢cient MDCK cells, the AE2 protein was localized to the
plasma membrane. In addition, we succeeded in transiently
transfecting two of these cell lines, CHO-K1 and MDCK
cells, with the GFP-AE2 fusion protein-encoding plasmid,
and found that the expressed fusion protein accumulated in
the Golgi membranes in CHO-K1 cells, and in the plasma
membrane in MDCK (Fig. 8). Jointly, these results together
with the data from COS-7 and HeLa cells (Figs. 1 and 2)
show that the localization of the AE2 protein in the Golgi
and thus also its detergent resistance (Fig. 4) strictly correlate
with the expression of Ank195 in the trans-Golgi.
Finally, we compared the subcellular distribution of the
GFP-AE2 fusion protein and Ank195 in COS-7 and HeLa
cells, after transient transfection of the cells with the GFP-
AE2 fusion protein-encoding plasmid. Cells were stained with
the Ank195 antiserum after detergent extraction. The results
showed that the GFP-AE2 fusion protein and Ank195 indeed
co-localize in the Golgi region in COS-7 cells but not in HeLa
cells (Fig. 9). Both proteins were detected in the same highly
compact juxtanuclear Golgi structure. In non-expressing cells
(Fig. 9), Ank195 staining was more di¡use, suggesting that
overexpression of the AE2 protein induces coalescence of
Ank195 into AE2-enriched membranes. Such Golgi accumula-
tion or GFP-AE2 coalescence was not observed in Ank195-
de¢cient HeLa cells.
4. Discussion
To better understand the variable subcellular distribution of
the AE2 protein in vivo, we have explored here the possibility
that the full-length AE2 protein is targeted to di¡erent sub-
cellular membrane systems in a cell type-dependent manner.
By using mainly ¢broblast-like COS-7 cells and epithelial
HeLa cells as target cells, we have shown that the endogenous
full-length AE2 protein and its GFP- or DsRed-tagged var-
iants are indeed targeted either to the Golgi apparatus in
COS-7 cells or to the plasma membrane in HeLa cells. This
Fig. 8. Localization of the AE2 protein in NRK, CHO-K1, MDCK
and MDBK cells. Top: Cells were grown on glass coverslips, ¢xed
and stained with the anti-AE2 C-terminal antibodies. Note that the
AE2 protein is localized in the Golgi membranes only in NRK,
CHO-K1 and MDBK cells, which express the Ank195 isoform (com-
pare with Fig. 7). In Ank195-de¢cient MDCK cells, AE2 is localized
predominantly to the plasma membrane. Bars, 10 Wm. Bottom:
Transient transfection of CHO-K1 and MDCK cells with the GFP-
AE2 fusion protein-encoding plasmid. Note the localization of the
fusion protein in the Golgi in Ank195-expressing CHO-K1 cells, and
in the plasma membrane in Ank195-de¢cient MDCK cells.
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cell type-dependent targeting to the Golgi apparatus was the
predominant one in most cells studied, and was found to
correlate strictly with the expression of Ank195, a trans-Gol-
gi-associated membrane skeletal protein that has a high po-
tential to interact with the AE2 protein. Although we failed to
demonstrate their direct interaction in vivo, their similar de-
tergent resistance, co-localization and coalescence, as well as
the predominant localization of these two proteins on the
trans side of the Golgi stack [26,32] all suggest that it is the
direct interaction of these two proteins that is responsible for
this cell type-dependent sorting of the AE2 protein in the
Golgi. To our knowledge, this is the ¢rst description at the
molecular level that targeting of this class of proteins does not
seem to depend strictly on sequence-speci¢c sorting motif(s)
buried in the protein’s primary structure. As such, our results
may also explain at least some of the controversies that are
related to the variant subcellular localization of the AE pro-
teins in di¡erent tissues and cell types.
Cell type-dependent targeting mechanisms, as suggested by
our data, do not preclude the existence of variant-speci¢c
targeting mechanisms that have been characterized recently
mainly using chicken erythrocytes as a model system [9,10].
Rather, the suggested cell type-dependent mechanism can be
regarded as an additional way to regulate the distribution of
the AE2 protein, and perhaps also its homologues, between
di¡erent subcellular membrane systems. It may be the pre-
dominant mechanism in mammalian cells, however. Interest-
ingly, both mechanisms seem to utilize the same ankyrin-de-
pendent localization mechanism, but in a di¡erent way.
Variant-speci¢c targeting has been shown to rely on alterna-
tive splicing and/or the use of alternative promoters [18],
whereas the cell type-dependent mechanism suggested here
appears to be based on the di¡erential expression of Ank195
between cells.
Our ¢ndings together with the previous data described
above emphasize an important role for ankyrins (and perhaps
for other cytoskeletal/cytoplasmic proteins such as kanadap-
tin) as the main determinants for the variable localization of
AE proteins in various tissues and cells in vivo. However, it is
not known whether the potential interaction of these two
proteins is itself su⁄cient for the localization of the AE pro-
teins. Several Golgi-speci¢c targeting mechanisms and signals
have been put forward during the last decade. These include
oligomerization, kin recognition, and the thickness of the lipid
bilayer [40^43]. Given the roughly similar oligomerization
states of the AE2 protein in COS-7 and HeLa cells, oligome-
rization itself appears not to be the primary cause for Golgi
localization of the AE2 protein. Oligomerization may, how-
ever, indirectly a¡ect localization, because ankyrin binding
has been reported to be required for AE1 tetramerization
[44]. In addition to our data (Fig. 3B) the ability of the
AE2 protein to form oligomers has also been demonstrated
with the use of cross-linking agents [45]. In this context, it
should be noticed that our data also do not exclude the pos-
sibility that the plasma membrane-localized AE2 protein may
associate with some distinct ankyrin isoform(s) that, however,
have to be detergent-soluble based on our Triton X-100 sol-
ubility assays (Figs. 4 and 5). This view is also supported by
the observed co-localization of the two proteins in the baso-
lateral membrane of kidney epithelial cells [15] or gastric pa-
rietal cells [17] and the in vitro binding of the erythrocyte
ankyrin to the N-terminus of AE2 [17].
A well-organized membrane skeleton in erythrocytes is
known to be necessary for the structural integrity, mechanical
stability and deformability of erythrocytes. The Golgi mem-
brane skeleton has been suggested to have a similar mem-
brane-stabilizing role in non-erythroid cells, perhaps by pro-
viding a platform for organized distribution of various
Fig. 9. Co-localization of the GFP-AE2 fusion protein and Ank195 in COS-7 cells. Cells transfected with the GFP-AE2 fusion protein construct
were ¢rst extracted with Triton X-100, and then ¢xed and stained with the anti-Ank195 antibody. Note the co-localization and coalescence of
the Ank195 and the GFP-AE2 fusion protein in the Golgi area in COS-7 cells (arrows), and the more disperse staining pattern of Ank195 in
neighboring non-transfected cells. In detergent-extracted HeLa cells, however, no Golgi-localized AE2 or Ank195 is detectable. Note also the
staining of the nuclei (asterisks) in detergent-extracted COS-7 and HeLa cells. Bars, 10 Wm.
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cytoplasmic and Golgi membrane proteins [46]. Golgi mem-
brane skeletal proteins have also been suggested to facilitate
e⁄cient transport of some speci¢c membrane proteins be-
tween the endoplasmic reticulum and the Golgi apparatus
[47]. In either case, the AE2 protein may have a crucial
role. First, the AE2 protein may have a pure structural role
in the Golgi, and may provide a membrane anchorage site for
the Golgi membrane skeletal proteins via Ank195, perhaps in a
phosphorylation-dependent manner [48]. Indeed, our recent
data (Holappa et al., submitted) indicate that the AE2 protein
is necessary for the structural integrity of the Golgi apparatus
in COS-7 cells. The known ion transport properties of the
AE2 protein in turn seem to provide an additional possibility
to regulate Golgi pH and its pH-dependent functions, such as
glycosylation, protein sorting and e⁄cient vesicular tra⁄cking
through this organelle. The predominant (but not exclusive)
expression of the AE2 protein at the plasma membrane in
HeLa and MDCK cells is also not in contrast with either of
the two possibilities, and may in fact re£ect a speci¢c need of
some epithelial cell types to express the AE2 anion exchanger
at the plasma membrane.
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